Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.

Please provide your email address to receive an email when new articles are posted on . The treatment group had reductions in FeNO 1 week after a single dose. Reductions were significant compared with ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Current asthma biologics require frequent dosing.

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "TSLP Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on approved drugs and drug ...

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "TSLP Inhibitors and TSLP Receptor Antagonists: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...

CS2015 potently interrupted the engagement of hOX40L on hOX40 reporter cells and hTSLP on hTSLPR/IL-7Rα reporter cells, respectively; The blocking activities of CS2015 were comparable to those of ...

- Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to ...

Scientists looking for novel ways to treat type 2 diabetes have stumbled across a mechanism by which the immune system can trigger the secretion of fat cells through the skin. The mechanism may ...

The cytokine thymic stromal lymphopoietin (TSLP) has previously been linked to allergic inflammatory diseases in humans. Now, three recent studies have confirmed that TSLP is a key initiator of ...

Thymic stromal lymphopoietin (TSLP) is an interleukin-7-like cytokine that is associated with the pathology of atopic dermatitis and asthma. Although the role of this cytokine has been studied in ...